Orbimed

Closed
Call
Website
601 Lexington Ave
New York, NY 10022
+1 (212) 739-6400
http://www.orbimed.com

OrbiMed is a global investment firm focused on advancing healthcare by providing tailored financing solutions to world-class companies across various sectors, including biopharmaceuticals, medical devices, and digital health. With over 25 years of experience and approximately $17 billion in assets under management, OrbiMed is dedicated to driving innovation and improving patient outcomes through global investment in healthcare enterprises.

The firm manages a diverse portfolio of over 500 companies, including leaders in cancer care, immunology, and targeted therapies. Their team of more than 130 professionals leverages scientific expertise and strategic insights to identify and support innovations that enhance the quality of life for patients worldwide.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

The Starr Foundation
General practice attorney, lawyer, Business services, nec, nec, Services, nec, nec

The Starr Foundation

The Starr Foundation is a prominent private foundation based in New York City, established in 1955 by Cornelius Vander Starr, an insurance entrepreneur. With assets totaling approximately $1.5 billion, it has become one of the largest private foundations in the United States, under the leadership of Maurice R. Greenberg. The foundation has made substantial grants exceeding $3.8 billion worldwide, focusing on areas such as education, medicine and healthcare, human needs, public policy, culture, and the environment.Generated from the website
Business services, nec, nec, Services, nec, nec

RM Global Bioaccess Fund Management

RM Global BioAccess Fund Management is dedicated to accelerating innovative science to develop new medicines through strategic partnerships with forward-thinking companies. The fund focuses on transformative technologies aimed at addressing significant unmet medical needs in oncology, rare diseases, central nervous system (CNS) disorders, and cardiology. With a commitment to investing in early-stage companies, the Global BioAccess Fund provides essential capital to support investigational new drug (IND) submissions and clinical trials. Their mission centers around fostering advancements in therapeutics and devices that can ultimately improve patient outcomes in critical health areas. Generated from the website
Business services, nec, nec, Services, nec, nec, Real estate managers

Madison Paige Capital

Contact us at (844) 865-7785 in New York, NY, to invest through mortgage-based financial services from our holding company.
United States›New York›New York›Orbimed